Sage Journals: Discover world-class research

Abstract

Objectives

To investigate clinicopathologic and treatment factors associated with survival in adult head and neck sarcomas in the National Cancer Database (NCDB). To analyze whether treatment settings and therapies received influence survival outcomes and to compare trends in utilization via an aggregated national data set.

Study Design

Prospectively gathered data.

Setting

NCDB.

Subjects and Methods

The study comprised a total of 6944 adult patients treated for a head and neck sarcoma from January 2004 to December 2013. Overall survival (OS) was the primary outcome.

Results

Increased age and tumor size, nodal involvement, and poorly differentiated histology had significantly reduced OS (P < .001). Angiosarcoma, malignant nerve sheath tumor, malignant fibrous histiocytoma, osteosarcoma, and rhabdomyosarcoma histologic subtypes had significantly reduced OS, while liposarcoma, chondrosarcoma, and chordoma had improved OS (P < .001). Utilization of surgical therapy was associated with improved OS, while positive surgical margins were associated with treatment at a community-based cancer program and had reduced OS (P < .001). On multivariate analysis, treatment with radiation and/or chemotherapy was not significantly associated with OS; however, primary treatment with definitive chemoradiotherapy had significantly reduced OS. Patients treated at academic/research cancer programs (n = 3874) had significantly improved 5- and 10-year OS (65% and 54%, respectively) when compared with patients treated at community-based cancer programs (n = 3027; 49% and 29%; P < .001). The percentage utilization of these programs (56% vs 44%) did not change over the study period.

Conclusion

For adult head and neck sarcomas, treatment at an academic/research cancer program was associated with improved survival; however, despite increasing medical specialization, the percentage utilization of these programs for this rare tumor remains constant.

Keywords

adult head and neck sarcomas survival outcomes overall survival National Cancer Database population-based study improved survival at academic facilities/sites

Get full access to this article

View all access options for this article.

References

Colville

Charlton

Kelly

Nicoll

McLean

. Multidisciplinary management of head and neck sarcomas. Head Neck. 2005;27:814-824.

Stavrakas

Nixon

Andi

et al . Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol. 2016;130:850-859.

Chao

Sturgis

Skoracki

Guadagnolo

Hanasono

. Reconstructive outcomes in patients with head and neck sarcoma. Head Neck. 2013;10:677-683.

Derbel

Heudel

Cropet

et al . Survival impact of centralization and clinical guidelines for soft tissue sarcoma (a prospective and exhaustive population based cohort). PLOS One. 2017;12(2):e0158406.

Paszat

O’Sullivan

Bell

et al . Processes and outcomes of care for soft tissue sarcoma of the extremities. Sarcoma. 2002;6:19-26.

Ray-Coquard

Thiesse

Ranchere-Vince

et al . Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol. 2004;15:307-315.

Bhangu

Beard

Grimer

. Should soft tissue sarcomas be treated at a specialist centre? Sarcoma. 2004;8:1-6.

Chang

Chai

Pollack

et al . Analysis of clinical prognostic factors for adult patients with head and neck sarcomas. Otolaryngol Head Neck Surg. 2014;151:976-983.

Tajudeen

Fuller

Lai

et al . Head and neck sarcomas: the UCLA experience. Am J Otolaryngol. 2014;35:476-481.

10.

Park

Roh

Kim

et al . Prognostic factors and oncological outcomes of 122 head and neck soft tissue sarcoma patients treated at a single institution. Ann Surg Oncol. 2015;22:248-255.

11.

Breakey

Crowley

Anderson

Milner

Ragbir

. The surgical management of head and neck sarcoma: the Newcastle experience. J Plast Reconstr Aesthet Surg. 2017;70:78-84.

12.

Peng

Grogan

Wang

. Head and neck sarcomas: analysis of the SEER database. Otolaryngol Head Neck Surg. 2014;151:627-633.

13.

Chen

Fedewa

Pavluck

Ward

. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116:4744-4752.

14.

Sturgis

Potter

. Sarcomas of the head and neck region. Curr Opin Oncol. 2003;15:239-252.

15.

Ellis

Gerry

Byrd

. Head and neck chondrosarcomas: analysis of the Surveillance, Epidemiology, and End Results database. Head Neck. 2016;38:1359-1366.

16.

Giuffrida

Burgueno

Koniaris

et al . Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063-1072.

17.

Gerry

Fox

Spruill

Lentsch

. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non–head and neck sites. Head Neck. 2014;36:393-400.

18.

Dettenborn

Wermker

Schulze

et al . Prognostic features in angiosarcoma of the head and neck: a retrospective monocenter study. J Craniomaxillofac Surg. 2014;42:1623-1628.

19.

Morgan

Swann

Somach

Eng

Smoller

. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874.

20.

Deyrup

McKenney

Tighiouart

Folpe

Weiss

. Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol. 2008;32:72-77.

21.

Kraus

Dubner

Harrison

et al . Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer. 1994;74:697-702.

22.

Farhood

Hajdu

Shiu

Strong

. Soft tissue sarcomas of the head and neck in adults. Am J Surg. 1990;160:365-369.

23.

Bentz

Singh

Woodruff

et al . Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol. 2004;11:619-628.

24.

Cannon

Sowder

Buchmann

et al . Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: a population-based study. Head Neck. 2017;39:82-91.

25.

Sowder

Cannon

Buchmann

et al . Treatment-related determinants of survival in early-stage (T1-T2N0M0) oral cavity cancer: a population-based study. Head Neck. 2017;39:876-880.

26.

D’Cruz

Vaish

Napre

et al . Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373:521-529.

27.

Cannon

Dundar

Thomas

et al . Elective neck dissection for head and neck cutaneous squamous cell carcinoma with skull base invasion. Otolaryngol Head Neck Surg. 2017;156:671-676.

28.

Huang

Kaplan

et al . Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma. Lancet. 1995;345:759-761.

29.

Lebbe

Blum

Pellet

et al . Clinical and biological impact of antiretroviral therapy with protease inhibitorson HIV related Kaposi’s sarcoma. AIDS. 1998;12:F45-F49.

30.

Mohanty

Bilimoria

. Comparing national cancer registries: the National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol. 2014;109:629-630.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.57 MB

Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis

Abstract

Objectives

Study Design

Setting

Subjects and Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material